Cantillon Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$355M Sell
876,265
-25,508
-3% -$10.3M 2.05% 24
2025
Q1
$449M Sell
901,773
-28,097
-3% -$14M 2.91% 13
2024
Q4
$484M Buy
929,870
+130,870
+16% +$68.1M 2.92% 14
2024
Q3
$494M Sell
799,000
-23,838
-3% -$14.7M 3.02% 13
2024
Q2
$455M Sell
822,838
-41,876
-5% -$23.2M 3.04% 11
2024
Q1
$503M Sell
864,714
-17,303
-2% -$10.1M 3.16% 11
2023
Q4
$468M Sell
882,017
-21,746
-2% -$11.5M 3.13% 12
2023
Q3
$457M Sell
903,763
-3,451
-0.4% -$1.75M 3.39% 8
2023
Q2
$473M Buy
907,214
+87,092
+11% +$45.4M 3.31% 9
2023
Q1
$473M Sell
820,122
-14,827
-2% -$8.55M 3.85% 5
2022
Q4
$460M Sell
834,949
-16,490
-2% -$9.08M 3.89% 7
2022
Q3
$432M Sell
851,439
-6,767
-0.8% -$3.43M 3.91% 5
2022
Q2
$466M Sell
858,206
-4,695
-0.5% -$2.55M 3.89% 6
2022
Q1
$510M Buy
862,901
+24,611
+3% +$14.5M 3.64% 7
2021
Q4
$559M Sell
838,290
-62,921
-7% -$42M 3.69% 5
2021
Q3
$515M Sell
901,211
-15,459
-2% -$8.83M 3.51% 8
2021
Q2
$462M Sell
916,670
-12,734
-1% -$6.42M 3.11% 12
2021
Q1
$424M Sell
929,404
-34,796
-4% -$15.9M 3.09% 12
2020
Q4
$449M Sell
964,200
-4,781
-0.5% -$2.23M 3.37% 13
2020
Q3
$428M Sell
968,981
-11,867
-1% -$5.24M 3.58% 11
2020
Q2
$355M Buy
980,848
+10,323
+1% +$3.74M 3.09% 14
2020
Q1
$275M Sell
970,525
-1,256
-0.1% -$356K 3.04% 15
2019
Q4
$316M Sell
971,781
-21,083
-2% -$6.85M 2.94% 17
2019
Q3
$289M Sell
992,864
-8,117
-0.8% -$2.36M 2.81% 17
2019
Q2
$294M Sell
1,000,981
-20,764
-2% -$6.1M 2.97% 18
2019
Q1
$280M Sell
1,021,745
-3,185
-0.3% -$872K 2.97% 17
2018
Q4
$229M Buy
1,024,930
+489,081
+91% +$109M 2.77% 17
2018
Q3
$131M Buy
+535,849
New +$131M 1.47% 31